Pooled statistical meta-analyses and systematic reviews aggregating thousands of patients across multiple randomized controlled trials to measure true effect size. Every study summary reports the trial design, participant sample size (N), primary outcome highlight, and direct link to the formal NCBI PubMed or federal record.
The Plain-English Receipt: Only 1.2% of prediabetic adults on Tirzepatide progressed to Type 2 diabetes over 3.4 years vs. 19.3% on placebo (Absolute Risk Reduction = 18.1% • Number Needed to Treat = 6).
Loxenatide combined with metformin was identified as the most economical choice, while the long-term health benefits of patients taking the six GLP-1RAs are approximate.
Our results suggest that there is a significant association between the reduction of in-hospital mortality and outpatient metformin therapy for type 2 diabetes in patients hospitalized for COVID-19.
The reduction of DBP is greater treated with telmisartan than perindopril in patients with essential high blood pressure (Tab.
Our MR study confirmed that earlier menstrual age, high blood pressure, obesity, and elevated 2-hour glucose post-challenge were risk factors for uterine leiomyoma, and the causal relationship between smoking and uterine...
Importantly, a meta-analysis of published clinical trials and a prospective real-world analysis of patients prescribed single blood-pressure-lowering agents for 6 mo and followed up 1 yr later both show that dihydropyridines...
Is fracture risk altered by PCOS?
Our metaanalysis reports a positive association between OSA and FES, with increasing severity of OSA correlating with a significantly higher risk of FES.
Dulaglutide caused the lowest intolerable GI AEs, while Liraglutide and Semaglutide were the highest.
The administration of once-weekly Semaglutide exhibited a substantial reduction in HbA1c, average systolic blood pressure (SBP), mean diastolic blood pressure (DBP), body weight, waist circumference, body mass index (BMI), and...
Melatonin did not appear to be effective in adults but might be effective in children and adolescents with chronic trouble sleeping for both comorbid trouble sleeping and non-comorbid trouble sleeping.
Sleep disorders are common in children with CKD.
Central AHI and obstructive AHI are greater in healthy newborns than older children.
This meta-analysis found a substantially high prevalence of sleep disorders including SWD, OSA, trouble sleeping, and EDS among first responders for medical emergencies.
These sleep disturbances may further contribute to an inflammatory state, due to the bi-directional relationship between sleep and immunity.
TRT can significantly improve metabolic indexes in patients with hypogonadism, though further studies are needed to confirm its long-term real-world benefits and safety in patients with metabolic disorders.
This meta-analysis suggests PDE-5i use in pregnancy is associated with mild maternal side effects and lower risk of operative birth for intrapartum fetal distress.
The mixed approach combining a meta-analysis and disproportionality analysis showed that statin use was associated with the occurrence of DAP-related rhabdomyolysis.
Current evidence supports the positive properties of flavonoids on ovarian histomorphology and hormonal status in animal models of PCOS.
This study suggests a bidirectional association between psoriasis and hair loss areata.
Seven trials (6609 participants) were included.
Our findings suggested that TST can enhance blood sugar control and hormone levels and reduce total cholesterol, triglyceride, LDL cholesterol whereas increase HDL cholesterol in hypogonadal T2DM patients.
We conclude that the primary clinical benefits of metformin result from its insulin-sensitizing and antihyperglycaemic effects that secondarily contribute to a reduced risk of a number of diseases and thereby enhancing healthspan.
No statistically significant difference between statin pretreatment and placebo (OR 0.87; 95% CI: 0.71-1.07, P = 0.18) as well as for atorvastatin (OR 0.88; 95% CI: 0.61-1.28; P = 0.48; I 2 = 84%) and rosuvastatin (OR 0.87;...
Eszopiclone and lemborexant had a favorable profile, but eszopiclone might cause substantial side effects and safety data on lemborexant were inconclusive.
However, it is worth noting that the findings are limited by the considerable heterogeneity of the studies, all of which were observational and retrospective in nature.
Due to possible long-term adverse effects of high-dose UVA1, medium-dose UVA1 cold light appears to be the superior form for AD.
All eight antihyperglycemic drug classes, taken in combination with metformin, reduced HbA1c levels; however, the effects of the agents on other outcomes varied among the classes.
We identified a total of 3,059 studies and finally included 15 studies in the meta-analysis.
Liraglutide add-on therapy reduced HbA1c levels without increasing low blood sugar incidence, independent of BMI, in insulin non-responders with type 2 DM.
The PubMed search yielded 848 records; after the 2 stages of screening, 23 studies were eligible for quantitative analyses.
Traditional health headlines often exaggerate findings by reporting only Relative Risk Reduction—for example, claiming a drug cuts risk by 50% when the event rate dropped from 2% to 1% (an Absolute Risk Reduction of just 1.0 percentage point, meaning 100 patients must take the drug for 1 person to benefit, or NNT = 100). On dotMD, every flagship study breakdown reports both Relative Risk and Absolute Risk alongside the exact sample size (N) and trial duration.
Every study on dotMD displays its exact Study Design Tier at the top of the card (Phase 3 Randomized Trial, Randomized Controlled Trial, Meta-Analysis & Systematic Review, Multi-Trial Clinical Evidence Synthesis, Journal Watch Cohort, or FDA Safety Alert) along with the human participant count (N). Preclinical mouse or cell-culture data is never presented as human clinical proof.
Arbitrary 0-to-100 rigor scores obscure what actually makes a study trustworthy. Instead of synthetic scores, dotMD surfaces the verifiable primary evidence signals: exact NCBI PubMed IDs (PMID), ClinicalTrials.gov registration numbers (NCT), double-blind vs. crossover design, sample size (N), p-values / Hazard Ratios, and study limitations.
Medical research is only useful if you can act on it safely with your clinician. Every flagship research synthesis links directly to the parent Condition diagnostic cutoff guide, the Medication FDA DailyMed & CMS NADAC wholesale price ledger, the Supplement elemental weight decoder, and our High-CPT-Volume Specialist Directory.
